Achillion Pharmaceuticals, Inc.
(NASDAQ : ACHN)

( )
ACHN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
-0.37%86.271.3%$1274.24m
AMGNAmgen Inc.
0.97%203.881.2%$676.03m
GILDGilead Sciences, Inc.
0.77%69.180.9%$577.80m
LOXOLoxo Oncology Inc
0.11%233.5012.7%$474.39m
BIIBBiogen Inc.
-0.27%337.421.3%$459.87m
ILMNIllumina, Inc.
0.87%312.753.5%$351.51m
VRTXVertex Pharmaceuticals Incorporated
2.19%194.701.9%$332.94m
REGNRegeneron Pharmaceuticals, Inc.
0.35%418.842.6%$322.26m
ALXNAlexion Pharmaceuticals, Inc.
2.12%117.052.0%$239.80m
TSROTESARO, Inc.
0.03%74.9614.4%$196.22m
AAgilent Technologies, Inc.
2.10%72.311.5%$166.45m
EXASExact Sciences Corporation
4.19%78.8025.3%$156.07m
INCYIncyte Corporation
-0.32%78.422.5%$153.20m
SRPTSarepta Therapeutics, Inc.
1.22%122.8015.4%$142.40m
LGNDLigand Pharmaceuticals Incorporated
6.49%117.9023.1%$123.00m

Company Profile

Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.